New York State Common Retirement Fund
INKT icon

New York State Common Retirement Fund’s MiNK Therapeutics INKT Stock Holding History

New York State Common Retirement Fund’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3
Closed -$65 – 3318
2023
Q2 		$65 Buy
+3
New +$60 ﹤0.01% 3429
2022
Q2 		– Sell
-800
Closed -$18K – 3509
2022
Q1 		$18K Hold
800
– – ﹤0.01% 3293
2021
Q4 		$36K Buy
+800
New +$95.1K ﹤0.01% 3265

Other funds holding INKT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New York State Common Retirement Fund's INKT Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of MiNK Therapeutics (INKT) in Q3 2023, closing a stake of 3 shares — an estimated $65 sold.

New York State Common Retirement Fund first reported a position in INKT in Q4 2021 and held it in 3 quarters. The position peaked at $36K in Q4 2021. 34 funds tracked by Wall St. Rank hold INKT as of Q3 2023.

  • New York State Common Retirement Fund reported no remaining MiNK Therapeutics position as of Q3 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 3 MiNK Therapeutics shares in Q3 2023, an estimated $65.
  • New York State Common Retirement Fund first reported a position in MiNK Therapeutics in Q4 2021 and held it in 3 quarters.
  • New York State Common Retirement Fund's MiNK Therapeutics position peaked at $36K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.